ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

Centers Can Collaborate Well with Industry, Albert LoBuglio Says

May 7, 1999

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992